Keywords: odac, avastin, breast, cancer, food, drug, administration

ODAC

Article | 10 December 2007

Print This

The US Food and Drug Administration's Oncologic Drugs Advisory Committee has voted five to four against approving the anticancer agent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in